ARCHIVES

Two Phase II Ibrutinib Studies Presented to EHA Demonstrate Efficacy as a Monotherapy

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Cancer Policy: Board Plans Paper On Tobacco Control

June 13, 1997

NIH Signs Agreement For Use Of Five Stem Cell Lines.

September 7, 2001

In Brief: Administration Backs Down On a Attempt To Kill General Research Support, Will Try To Modify It

November 1, 1974

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002

Henschke Responds To Articles On I-ELCAP.

January 12, 2007

In Brief: Streamlining Of Contract Award Process Still Top Priority At NCI; Training Grants No Closer

January 10, 1975